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Abstract – Due to the probable role played by rodents as a reservoir for the transmission of the EMC
virus to pigs, the experiment reported here was performed in order to assess the transmission rate of
EMCV within a rat population. Twenty-five eight-week-old Wistar rats housed in individual plastic
cages were experimentally infected either with a Greek myocardial EMCV strain (5 rats with a 0.2
× 106 TCID50 dose per rat and 10 rats with a 0.5 × 104.5 TCID50 dose per rat, oronasally) or a
Belgian myocardial EMCV strain (10 rats with a 0.5 × 104.5 TCID50 dose per rat, oronasally). Two
to five days later, each inoculated rat was moved to a new clean cage and coupled with a contact rat
to compare the pathogenicity of the two strains and to estimate the basic reproduction ratio R0,
indicating the level of EMCV transmission. During the experiments, faecal virus excretion was
measured as well as the serological response against EMCV. After euthanasia, virus isolation was
attempted from different rat tissues. Neither strains produced mortality, nor clinical signs and only
low titres of neutralising antibodies were found. All contact rats, however, were infected and the
virus was isolated from their faeces and from various tissues. Both 10-pair experiments revealed a
point estimate for the R0 of  (95%-CI for both the Greek and Belgian EMCV strains = 4.48 − ),
as did the 5-pair experiment with a higher dose of the Greek strain (95%-CI = 1.83 − ). Combining
the results from the two 10-pair experiments resulted in an estimate for R0 of  (95%-CI: 9.87 −). These results indicate that the EMC virus can spread very easily within a rat population by
horizontal rat-to-rat transmission (R0 >> 1). 
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1. INTRODUCTION
Encephalomyocarditis virus (EMCV) is
a member of the genus Cardiovirus of the
family Picornaviridae, with a worldwide
distribution [13]. Rodents are considered
as the natural host of EMCV [1]. 
In domestic pigs, EMCV has been rec-
ognised either as a cause of mortality in
young pigs, due to acute myocarditis, or of
reproductive failure in sows [27]. The myo-
cardial form has been reported in young
pigs in Greece [18, 22], Italy [14, 24],
Cyprus [18] and Belgium [17, 18]. The
reproductive form, characterised by abor-
tions, still- or weakborn piglets and mum-
mification, has been reported in Belgium
only [15]. These apparently conflicting
reports suggest that EMCV strains may
vary in pathogenicity and tissue tropism.
Each form of the disease in pigs seems to
be restricted to certain geographical areas,
probably due to viral strains originating
from local rodent populations. With respect
to EMCV infections in pigs, at present time
two routes of infection are suggested for the
introduction and/or subsequent spread of
the virus within a pig farm. At first, pigs
might get infected by the ingestion of sub-
stances (e.g. faeces or carcasses) of infected
rodents [1, 20, 23]. The second route is hor-
izontal pig-to-pig transmission during the
short period of viraemia [4, 17] or after
reactivation of EMCV persistence [5].
From a recent study by Maurice et al. [21],
in which the EMCV transmission from pig-
to-pig contact was experimentally quanti-
fied, it can be concluded that the spread of
EMCV between pigs in most cases will be
limited. The high seroprevalence levels
found in the field and the observed clinical
infections in separated pens and compart-
ments of affected pig houses might there-
fore point to an additional spreading mech-
anism, for example via rodents. Although it
is known that rats can be infected with the
EMC virus [2], only little is known about
the spread of the virus within the rat popu-
lation. More insight into the transmission of
EMCV among rats might enlighten their
role as a possible transmitter or a potential
reservoir for the EMC virus and stress the
need for an effective rodent control pro-
gramme at the farm level. A commonly
used measure of the transmission of infec-
tious agents is the basic reproduction ratio
(R0), which is defined as the mean number
of new infections that one typical infectious
individual causes in a totally susceptible
population [3, 6]. R0 was used to quantify
the transmission of the EMC virus among
rats. 
The purpose of the present experimental
work was (a) to study the pathogenicity of
two EMCV strains for rats and (b) to
experimentally quantify the horizontal rat-
to-rat transmission of EMCV. An R0-value
above one would indicate that the EMCV
virus is able to spread within the rat popu-
lation by horizontal rat-to-rat transmission
and therefore the hypothesis H0: R0 < 1
was tested.
2. MATERIALS AND METHODS
2.1. Animals and experimental design
Fifty eight-week-old Wistar rats were
obtained from the Theagenion Anticancer
Institute of Thessaloniki, Greece. The rats
were free of EMCV as assessed by serolog-
ical and virological examinations before
inoculation.
Three experiments were conducted suc-
cessively, studying the pathogenicity and
transmissibility of two EMC virus isolates.
In each experiment, the rats were randomly
assigned into two groups and each rat was
housed in an individual plastic cage (26 ×
20 × 14 cm). In experiment A, ten rats were
infected oronasally with a 0.5 × 104.5 TCID50
dose per rat of the Greek strain 424/90. Two
days after infection each rat was transferred
to a new clean cage, together with an unin-
fected contact rat. Infected and contact rats
were euthanized 18 to 59 days post infec-
tion (p.i.) (Tab. I). In experiment B, ten rats
were infected oronasally with a 0.5 ×
104.5 TCID50 dose per rat of the Belgian
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strain B275/95. Two days after infection
each rat was transferred to a new clean cage,
together with an uninfected contact rat.
Infected and contact rats were euthanized
11 to 62 days p.i. (Tab. II). In experiment
C, five rats were infected oronasally with a
0.2 × 106 TCID50 dose per each rat of the
Greek strain 424/90. To quantify the rat-to-
rat transmission in experiment C, each rat
was transferred to a new clean cage together
with an uninfected contact control rat, at
predetermined (2 to 5) days after infection.
Infected rats were euthanized 3 to 7 days p.i.
Contact rats were euthanized 20 to 23 days
post contact (p.c.) (Tab. III). 
In the current study, a contact rat was
considered infected when the virus could
be isolated from the faeces. After euthana-
sia, contact infection was confirmed by
virus isolation from various tissues. 
In all experiments, blood samples were
taken from each rat before inoculation and
on the day of death. Fresh faeces were col-
lected before inoculation and from 2 to 32
and on 58 and 59 days p.i. (experiment A),
from 2 to 32 and on 43 and 62 days p.i.
(experiment B) and from 2 to 23 days
p.i. (experiment C), except for those rats
that were killed earlier. After euthanasia,
necropsy was performed and samples from
the brain, thymus, heart, lung, liver, spleen,
kidney, pancreas and Peyer’s patches were
collected for virus isolation. 
2.2. Viruses
Two EMC virus strains were used. Strain
424/90 was isolated in Greece, in 1990,
from the myocardium of a three-month-old
pig in a breeding farm with the typical myo-
cardial form of EMCV [4]. Strain B279/95
was isolated during the first outbreak of
myocardial disease due to EMCV in fatten-
ers in Belgium in August 1995 [17]. Both
were isolated and passaged on baby ham-
ster kidney (BHK-21) cells. For the prepa-
ration of the viral inocula of the Greek
strain, a 4th passage was performed on the
same cell batch. The virus infectivity of the
stock was 106 TCID50/mL. In addition, for
the preparation of the viral inocula of the
Belgian strain the first passage was used.
The virus infectivity of the stock was
104.5 TCID50/mL. Infected cell culture flu-
ids were centrifuged for 5 min at 2 000 g to
remove cellular debris, mixed 1:1 with ster-
ile glycerol and stored at −20 °C. 
The identification of the viruses was per-
formed by neutralisation with a specific
EMCV antiserum, electron microscopy,
RNA-analysis and RT-PCR [16]. African
and classical swine fever viruses, parvovi-
rus, Aujeszky’s disease virus, swine vesic-
ular disease virus and porcine respiratory
and reproductive virus were not detected in
the inocula. Strain ATTC 129B was used
for serological analysis.
2.3. Serological assay
A virus neutralisation test (VNT) was
performed. Two-fold dilutions of serum
were made in minimum essential medium
(MEM) in 96-well flat-bottomed micro-
titration plates (Nunc, Denmark). One hun-
dred TCID50 of EMCV was added in equal
volume. The plates were incubated at 37 °C
in a 5% CO2 atmosphere for 1 h before
BHK-21 cells were added. The results were
usually read after a 48-h incubation. The
titres were expressed as the initial dilution
of the sera at the 50% end point according
to the method of Kärber [11]. The sera were
considered positive if the titre was equal to
or higher than 1/32 [19]. 
2.4. Virus isolation
Virus isolation was attempted from all
rats as previously described [22]. In short,
tissue supernatants were incubated on BHK-
21 cell monolayers. The faeces were diluted
1/10 in MEM with the addition of 600 mg/L
sulfadoxin, 120 mg/L trimethoprim and
500 000 IU/L of penicillin. After centrifu-
gation at 3 000 g for 10 min, the superna-
tants were processed as for tissue homoge-
nates. The samples that showed a cytopathic
effect were submitted to a neutralisation
test, using specific EMCV-antiserum to
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identify the isolate. Three blind passages of
3 days each were made of the negative sam-
ples.
2.5. Statistical analysis
The performed transmission experi-
ments were analysed by means of the
“general epidemic model” or SIR-model
(Susceptible-Infectious-Removed) [7]. The
probability distribution of the outcome of a
transmission experiment, which is the total
number of contact infections (final size),
can be described in terms of the transmis-
sion parameter R0 using an algorithm given
by De Jong and Kimman [8]. In the case
of a one-to-one or pairwise transmission
experiment, the outcome of the infection
process is a binary variable: contact infec-
tion occurs or not. Therefore, the total
number of observed contact infections in
n independent replications of a pairwise
transmission experiment is binomially dis-
tributed. The maximum likelihood estima-
tor (MLE) for the probability of infection is
then simply given by the observed propor-
tion of contact infections. If this informa-
tion is combined with the formula for the
final size algorithm, the MLE for R0 can be
described and calculated from the number
of contact infections and the number of rep-
etitions of the experiments [21, 26].  
In this study, the experiments A and B
can both be considered pairwise experi-
ments with 10 repetitions, while experi-
ment C consisted of 5 pairwise repetitions.
The boundaries of the 95% confidence
interval for R0 were calculated, together
with the p-values to test the null-hypothesis
H0: R0  1 [21]. The null hypothesis was
rejected when the probability was less than
0.05. 
3. RESULTS
3.1. Clinical signs
None of the inoculated or contact
infected rats showed any clinical signs nor
died. 
3.2. Serological assay
No neutralising antibodies were detected
in any of the rats before inoculation or con-
tact. However, neutralising antibodies in
low titres were detected in inoculated and
contact infected rats. However the titres
reached the cut-off value only in few rats of
experiment A and B and in no rat in exper-
iment C (Tabs. I, II and III). 
3.3. Macroscopic lesions
No macroscopical lesions were observed
in any organs of inoculated and contact
infected rats.
3.4. Virus isolation
 EMCV was isolated from the faeces of
both inoculated and contact rats between
days 2 and 29 in experiments A and B, and
2 and 20 in experiment C. In all experi-
ments, EMCV was only isolated from the
thymus and Peyer’s patches from rats
killed late post-infection (57−62 days post
inoculation or contact), whilst EMCV was
also isolated from several other tissues
in rats killed sooner after infection (3−
23 days) (Tabs. I, II and III). 
3.5. Quantification of EMCV 
transmission by means 
of the R0-value
A first estimate of the value of R0 for the
Greek EMC virus strain (G424/90) was
obtained from experiment A. The R0 was
estimated to be  (95%-CI = 4.48 − )
from the observed final size of 10 (total
number of contact infections in the 10 pair-
wise repetitions) and the null-hypothesis
R0 < 1 could be rejected (p = 0.000).
The data of experiment B with the Bel-
gian EMCV strain (B279/95) resulted in an
R0 value of infinity ( ) (95%-CI = 4.48 −), which also resulted in the rejection of
the null-hypothesis R0 < 1 (p = 0.000).
When the results for both the Belgian and
Greek EMCV strains (dose 104.5) were
≤
∞ ∞
∞
∞
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pooled, the point estimate for R0 did not
change ( ), but the lower limit of the con-
fidence interval was raised from 4.48 to
9.87 (95%-CI: 9.87 − ).
Also in the 5-pair experiment with the
Greek strain (high dose, 106 TCID50) all
contact rats were infected, again resulting
in a point estimate for R0 of infinity (95%-
CI: 1.83 − ) and again the null-hypothesis
(R0 < 1) was strongly rejected (p = 0.004).
4. DISCUSSION
4.1. Pathogenicity of EMCV among rats
In this experimental work, rats were
infected with two different myocardial
EMCV strains. 
After experimental infection with either
of the strains, none of the infected rats
showed any clinical signs nor died. The
inapparent infection of the rats was in
agreement with Findlay and Howard [9],
but was in contrast with Kilham et al. [12]
who described paralysis and death after the
experimental infection of albino rats with
EMCV. It was confirmed that rats survive
infective EMC doses that would be lethal
for piglets and mice, and they infect con-
tact rats. Transmission from rat-to-rat was
slow, slower than in pigs [4]. EMCV was
isolated from the faeces of both inoculated
and contact rats between days 2 and 29 in
experiments A and B, and 2 and 20 in
experiment C. Infected rats seem to excrete
the EMC virus in faeces for a longer period
than piglets do [4]. Taking into account the
resistance of all naked viruses in the envi-
ronment, the possibility of transmission
from rat-to-rat and rat-to-pig during this
period is evident. 
Neutralising antibodies were detectable
in both inoculated and contact rats inde-
pendently of the infectious dose. However,
the titres were low and delayed after infec-
tion. This may partly account for the long
viral excretion. In experiments A and B,
the titre reached the diagnostic cut-off
level of 1/32 [19] in only ten rats. On the
contrary, all rats in experiment C, which
were infected with a higher dose but killed
earlier, had titres lower than the diagnostic
cut-off. 
Following euthanasia, no macroscopi-
cal lesions were observed in any organs of
any of the rats. 
The virus was isolated from several tis-
sues of inoculated and contact infected rats
in all experiments independently of the
infectious dose. It was most frequently iso-
lated from Peyer’s patches and the thymus,
and less frequently from other tissues. The
number of positive tissues decreased with
time. It should be noticed that in rats killed
late post-infection, EMCV was isolated
from the thymus and Peyer’s patches only.
The presence of the virus in the lymphoid
tissues was in agreement with our previous
work on pigs [5], that the macrophages of
these tissues may indicate the sites of viral
persistence and routes of viral shedding. In
fact, the presence of virus in the Peyer’s
patches of most rats, in all experiments,
indicates that this tissue represents a site of
viral persistence after oral infection. 
4.2. Transmission of EMCV among rats
The second target of this experimental
work was to quantify the level of EMCV
transmission between rats, as measured by
the reproduction ratio R0. This parameter
has an important threshold; if R0 < 1, only
minor outbreaks will occur and an infec-
tion will die out, but if R0 ≥ 1, large out-
breaks are also possible [7]. Since rats or
rodents are often suggested as the potential
reservoir for the EMC virus on pig farms
[2, 25], information on the EMC virus
transmission among rats could be used to
ground this hypothesis. In many EMCV
outbreaks on pig farms, plagues of rats and
mice have been reported [2, 17, 23] and in
some of these outbreaks rodents were also
tested and found positive for EMCV on
virus isolation from organs and/or intes-
tines or faeces [2, 10, 17]. In this study, a
∞
∞
∞
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rat was considered infected when the EMC
virus could be isolated from its faeces and
contact infection was confirmed by virus
re-isolation from various tissues. Based on
the data from the current experiments A, B
(p = 0.000) and C (p = 0.004), the hypoth-
esis R0 ≤ 1 was strongly rejected for both
virus strains, indicating that each infected
rat would at least infect one other rat in a
totally susceptible population [3]. This
implies that EMCV can persist in the rat
population by rat-to-rat virus transmission
alone, which makes the rat population a
potential reservoir for EMCV on commer-
cial pig farms. 
4.3. Relation of EMCV outbreaks 
on pig farms
Currently suggested transmission routes
from rats to pigs are the following: (a)
ingestion of infected faeces from rodents
or (b) ingestion of infected rodent car-
casses [1, 20, 23].
The high R0, their survival to infection
and the long period with virus excretion in
the faeces could make rats a potential
threat to pigs on a pig farm. Recent find-
ings from a case study in Belgium by
Kluivers et al. (unpublished data) showed
that infection among pigs was widespread
throughout the affected compartment.
Findings from Maurice et al. [21], how-
ever, indicate that the pig-to-pig transmis-
sion in most cases will be limited (R0 close
to 1), suggesting that another species such
as rats could be involved in the epidemiol-
ogy of EMCV on pig farms. 
Additional research is needed to elabo-
rate the rat hypothesis and to test other
existing theories. Seaman et al. [23] has
suggested, for example, a role for mice in
the infection chain for EMCV, an idea that
might be supported by the finding of mice
as a risk factor for clinical EMC as found
by Maurice et al. [21]. 
From the current study, we conclude
that both EMCV strains are transmitted
very effectively among rats under experi-
mental conditions. This might imply that
they could play an important role in the
epidemiology of EMCV infections on pig
farms by either serving as a reservoir host
or as a transmitter of the virus to the pigs.
More insight is needed, however, in the
contact structure within the rat population
and their behaviour on pig farms. 
Experiments between rats and pigs,
with special emphasis on the infectious
dose from rats to pigs, could provide useful
information on the transmission of EMCV
between these species.
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